In conversation with... Shankar Siva
from Listen to The Lancet Oncology Hosted by The Lancet
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 8 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on November 28, 2022.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.